(MedPage Today) — MONTREAL — Patients with diabetic macular edema (DME) maintained improvements in visual acuity and retinal anatomy for up to 4 years with the ranibizumab port delivery system (PDS; Susvimo), according to updated results from…
Source: MedPage Today — Headlines
